Add to ORKGintervention in the prevention of heart failure for high-risk elderly patients in the communit
af cardiotonic drugs, diuretics, β-blockers, and angiotensin-converting-enzyme inhibitors (ACEI) can...
The online version of this article, along with updated information and services, is located on th
© 2015, publisher and license JDDT, This is an Open Access article which permits unrestricted noncom...
Is the high-risk strategy to prevent cardiovascular disease equitable? A pharmacoepidemiologica
Is cardiac resynchronisation therapy feasible, safe and beneficial in the very elderly
Improving appropriate polypharmacy for older people in primary care: selecting components of an evid...
Multidrug and optimal heart failure therapy prescribing in older general practice populations: a cli...
Therapeutic effect of interventional therapy for unprotected left main coronary artery lesions in ag...
<p></p><p><b> </b><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be...
Evidence-based therapies (EBTs) for the prevention of cardiovascular disease (CVD) are reportedly un...
Contains fulltext : 136510.pdf (Publisher’s version ) (Closed access)Purpose: medi...
Which people should take aspirin for primary prevention of cardiovascular disease
The impact of a decision aid about heart disease prevention on patients ' discussions with thei...
This article is freely available via Open Access. Click on the Additional Link above to access the f...
Underlying causes, risk factors, and precipitating causes of heart failure (HF) should be treated. P...
af cardiotonic drugs, diuretics, β-blockers, and angiotensin-converting-enzyme inhibitors (ACEI) can...
The online version of this article, along with updated information and services, is located on th
© 2015, publisher and license JDDT, This is an Open Access article which permits unrestricted noncom...
Is the high-risk strategy to prevent cardiovascular disease equitable? A pharmacoepidemiologica
Is cardiac resynchronisation therapy feasible, safe and beneficial in the very elderly
Improving appropriate polypharmacy for older people in primary care: selecting components of an evid...
Multidrug and optimal heart failure therapy prescribing in older general practice populations: a cli...
Therapeutic effect of interventional therapy for unprotected left main coronary artery lesions in ag...
<p></p><p><b> </b><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be...
Evidence-based therapies (EBTs) for the prevention of cardiovascular disease (CVD) are reportedly un...
Contains fulltext : 136510.pdf (Publisher’s version ) (Closed access)Purpose: medi...
Which people should take aspirin for primary prevention of cardiovascular disease
The impact of a decision aid about heart disease prevention on patients ' discussions with thei...
This article is freely available via Open Access. Click on the Additional Link above to access the f...
Underlying causes, risk factors, and precipitating causes of heart failure (HF) should be treated. P...
af cardiotonic drugs, diuretics, β-blockers, and angiotensin-converting-enzyme inhibitors (ACEI) can...
The online version of this article, along with updated information and services, is located on th
© 2015, publisher and license JDDT, This is an Open Access article which permits unrestricted noncom...